The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01908972|
Recruitment Status : Completed
First Posted : July 26, 2013
Results First Posted : October 26, 2018
Last Update Posted : December 19, 2018
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Single (Participant); Primary Purpose: Treatment|
Although the sample size in the present study was predetermined to show noninferiority, it is difficult to provide strong evidence of safety outcomes.
The present study was not a double-blind trial.